Cause of deadly neurological disease found
A drug may help children with Pelizaeus-Merzbacher disease, a deadly neurological disorder, according to a study by researchers at Stanford, UCSF and Cambridge.
SHC – ValleyCare earns stroke certification
The hospital’s stroke program can now provide swift service to residents of Dublin, Pleasanton and Livermore, who previously had to be transported elsewhere after suffering a stroke.
Jennifer Doudna to discuss CRISPR
Jennifer Doudna, who pioneered the gene-editing technology known as CRISPR-Cas9, will come to Stanford to discuss the ethics and future applications of the tool.
$4.75 million for high-risk, high-reward research
Jin Hyung Lee will receive $3.5 million to study the use of innovative technology to analyze brain circuitry, and Corey Keller will receive $1.25 million to fund work into brain stimulation treatments for mental illness.
Stanford honored for MD wellness efforts
Stanford Medicine’s commitment and work to improve physician fulfillment and reduce burnout have been acknowledged with the highest-level designation from the American Medical Association.
Cancer-drug combo extends life about 9 months
The results of a phase-3 clinical trial led by a Stanford researcher showed that two targeted treatments can extend the lifespan and delay the need for chemotherapy in women with a common type of metastatic breast cancer.
Grad students receive lab coats
During a ceremony at the Li Ka Shing Center, first-year doctoral students marked the beginning of their graduate careers by donning white lab coats and taking an oath of integrity.
Potential new way to detect, treat Parkinson’s
In human cell cultures, countering a defect that appears to be nearly universal among patients with Parkinson’s disease prevents death in the cells whose loss causes the disease.
Increasing teens’ sleep time
Stanford researchers increased how long teens slept with light therapy, used to reset their circadian clocks, combined with cognitive behavioral therapy to motivate them to go to bed earlier.
Substance may counter neurodegeneration
A Stanford research team has identified an oddball way brain cells spread inflammation in several neurodegenerative diseases — and an approach that could counter them all.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.